On this episode of our epic Election Night Special, we are joined by Mark Sebastian from The Option Pit.
OIRN Election Night Special Part 6: Uncle Mike, SpiderRock and The Great Wager
We are joined by St. Charles Wealth Management and SpiderRock Advisors.
Options Boot Camp 113: Stick It To ‘Em!!!
What strategy should you employ for your first options trade? Find out on this episode of Options Boot Camp.
OPR 341: Fly Away with a JETS Figleaf
Brian kicks things off by discussing last week’s pharmaceutical doppelganger strangle in Pfizer (PFE) and Johnson & Johnson (JNJ).? Then he talks about a figleaf trade in the airlines ((JETS ? JETS Airline ETF).
OIR Interviews: AI Invades The Options Brokerage World
Is it time for AI to invade the options brokerage world? Let’s find out on this episode of Options Insider Radio with guest CC Lagator from Options AI.
TCR 85: The Crypto Tsunami
Looking at bitcoin options volume and big trades on Deribit Exchange on this episode of The Crypto Rundown.
Option Block 954: Keeping Our Kung Fu Grip on Volatility
How does VOLQ fit vs. VIX when it comes to spreads? Debating that on this episode of The Option Block.
AO 97: The Great Advisor Resurgence Plus the Mysteries of Stock Substitution
Stocks are at a new all-time high. Might be a good time to consider stock substitution. What is it? Listen to this episode of The Advisors Option.
Volatility Views 424: A Heavy Weight On Volatility
What’s causing the Jan bump in VIX futures? Contested Election? Georgia Runoff? Something else? Debating this and more on this episode of Volatility Views.
TWIFO 226: 2020 CME Options Breakdown Plus CVOL Sneak Peek
Discussing the launch of their new implied volatility indexes CVOL with Derek Sammann from CME Group on this episode of This Week in Futures Options.
Option Block 953: FCEL, NVDA, Robinhood and…Space Lasers?
What the heck is going on in FCEL options? Find out on this episode of The Option Block.
OPR 340: Big Pharma Ratio Doppelganger Strangle
Brian tries out a pharmaceutical doppelganger strangle in Pfizer (PFE) and Johnson & Johnson (JNJ).










